Foundation Medicine (FMI) Misses Q1 EPS by 6c

Foundation Medicine (NASDAQ: FMI) reported Q1 EPS of ($0.59), $0.06 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $21 million.

Foundation Medicine sees FY2015 revenue of $105-115 million, versus the consensus of $108.7 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Innovaro (INV) Misses Q2 EPS by 9c
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance